Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / RLMD - Relmada Therapeutics Inc. (RLMD) CEO Sergio Traversa on Q2 2021 Results - Earnings Call Transcript

RLMD - Relmada Therapeutics Inc. (RLMD) CEO Sergio Traversa on Q2 2021 Results - Earnings Call Transcript

Relmada Therapeutics Inc.
Relmada Therapeutics, Inc. (RLMD) Q2 2021 Earnings Conference Call August 10, 2021, 16:30 ET Company Participants Timothy McCarthy - LifeSci Advisors Sergio Traversa - CEO & Director Charles Ence - Chief Accounting & Compliance Officer Charles Gorodetzky - Former Scientific Director, National Institute of Drug Abuse Addiction Research Center Conference Call Participants Marc Goodman - SVB Leerink Andrea Tan - Goldman Sachs Group Joon Lee - Truist Securities Jay Olson - Oppenheimer Eddie Hickman - Guggenheim Securities Andrew Tsai - Jefferies Presentation Operator Thank you for standing by. This is the conference operator. Welcome to the Relmada Therapeutics Second Quarter 2021 Earnings Call. [Operator Instructions]. I would now like to turn the conference over to Mr. Tim McCarthy from LifeSci Advisors. Please go ahead. Timothy McCarthy Thank you, Rachel, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa; and

For further details see:

Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q2 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Relmada Therapeutics Inc.
Stock Symbol: RLMD
Market: OTC
Website: relmada.com
Menu
RLMD RLMD Quote RLMD Short RLMD News RLMD Articles RLMD Message Board
Get RLMD Alerts

News, Short Squeeze, Breakout and More Instantly...